Research hopes to use ‘ecstasy’ drugs to reduce social anxiety in adults with autism

A team of researchers recently revealed their plans to study the therapeutic effects of a drug called ecstasy, which is deemed illegal in most (if not all) of the countries in the world today.

In a review recently published in the Progress in Neuro-Psychopharmacology & Biological Psychiatry journal, the researchers laid out their plans to examine the therapeutic effects of the substance, which is also known by its medical name— MDMA.

Researchers hope to administer ecstasy in clinical settings and in infrequent intervals on minimal doses, with the aim of reducing social anxiety in individuals with autism. It is also hoped that the drug will help improve relationships between the individuals and the therapists who attend to them.

Research on the therapeutic effects of MDMA has been around for decades. Scientists are also currently studying the beneficial effects of the drug to Post-Traumatic Stress Disorder (PTSD) patients, as well as its effects to behaviors of individuals with autism.

MDMA has been illegal in the U.S. for more around three decades, but positive effects of the drugs has been tested and found to promote good moods in individuals before it was declared illegal.

The drug has been made illegal due to its lethal effects on individuals who take the drugs in high doses.

Readers can find a previous article on this subject here:  Can Ecstasy Ease Symptoms of Autism?

Source: Lucy Clarke-Billings on the Independent: Autistic adults could take pure MDMA to ‘reduce social anxiety’